Kappa Bioscience, a Balchem company

Kappa Bioscience, a Balchem company since June 2022, is a Norwegian developer and manufacturer of high-purity vitamin K2 MK-7. Founded in 2006 and based in Oslo, Kappa specializes in bioactive nutritional ingredients aimed at health and wellness applications. The company emphasizes science-driven innovation and integrity, focusing on product synergies that support longevity, performance, bone health, heart health, immunity, and athletic performance.

Kappa produces K2VITAL®, a patented synthetic vitamin K2 with 99.7% all-trans purity, which is recognized as the reference standard in the United States. Its product line includes K2VITAL DELTA, the only patented microencapsulated vitamin K2, designed for stability in various functional foods and beverages. Kappa also develops advanced production technologies for higher purity vitamin K2 MK-7 and offers ingredient combinations with Balchem's portfolio, targeting solutions for cardiovascular health, cognition, and longevity. The company holds a strong market position in the vitamin K2 sector, serving the health and well-being industry with a focus on B2B supply.